PAMELA CLARKE: Open Payments
NPI 1518483023 · PRINCE GEORGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,461 in 42 payments from 18 companies in 2025. Trend: 2023 $22 · 2024 $603 · 2025 $1,461
Food & beverage: $1,461
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $381 |
| AstraZeneca Pharmaceuticals LP | 4 | $366 |
| PFIZER INC. | 4 | $162 |
| ABIOMED | 2 | $150 |
| Lundbeck LLC | 2 | $58 |
| Lilly USA, LLC | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| CARDIVA MEDICAL, INC. | 1 | $31 |
Products named: VRAYLAR, AIRSUPRA, VYNDAQEL, BREZTRI, REXULTI, LEQVIO, QULIPTA, FANAPT.
Industry payments across VA — which companies pay providers there.
